Terri Wilder, M.S.W.
Terri L. Wilder, M.S.W., has been part of the HIV community since 1989, and has been a reporter and writer for TheBody/TheBodyPro since 2007. She served on the New York Governor's Task Force to End AIDS, was recognized by POZ magazine for her work in HIV, and is highlighted in the book Fag Hags, Divas and Moms: The Legacy of Straight Women in the AIDS Community by Victoria Noe. She loves this community and will keep fighting until the epidemic is over.
Latest by Terri Wilder, M.S.W.
How to End COVID-19 and Other Pandemics With a Human Rights and Health Justice Approach
Natalia Linos, Sc.D., M.Sc., of Harvard University’s FXB Center for Health and Human Rights, calls for protections for low-wage essential workers and releasing people from jails, prisons, and ICE detention.
Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It
Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.
Governor Brian Kemp’s COVID-19 Response Has Georgia On This HIV Doctor's Mind
Dr. Melanie Thompson discusses what’s happening in the state around coronavirus, and what it means for people living with HIV.
Whether HIV or COVID-19, Pregnant or Lactating Cisgender Women Need to Be Included in Clinical Trials for Therapies
Dr. Shahin Lockman says to not include women in trials is unethical.
Creating Care Plans for People Who Use Drugs Or With Hepatitis C in the Time of Coronavirus
VOCAL-NY has kept its doors open through the COVID-19 pandemic to serve people who use drugs and may be living with hepatitis C, but how it provides services has changed.
How This Massachusetts Clinic Is Providing Transgender Care During the Coronavirus Pandemic
Telemedicine is helping keep transgender patients connected to care, but gaps still exist.
As With HIV, New York State Was Set to Lead the Nation to End Hepatitis C. But Why Haven’t the Recommendations Been Made Public?
Activist and member of the state task force Annette Gaudino would like the public to know.
Is Virologic Failure the Best Endpoint in Clinical Trials for Integrase Inhibitors?
Using data from the ADVANCE trial, this researcher suggests people with HIV with low-level viremia may still get to undetectable.
Oral Arguments in Antitrust Case Against HIV Drug Companies Began Last Week. Plaintiff Peter Staley Explains the Case
The case could change the way pharma companies make agreements to keep generic versions of single-tablet pills at bay.
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.